|
SEC61A2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.237800E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.400800E-01 |
| Normal-vs-Stage2 |
9.310800E-01 |
| Normal-vs-Stage3 |
1.101370E-01 |
| Normal-vs-Stage4 |
3.181200E-01 |
| Stage1-vs-Stage2 |
7.742800E-01 |
| Stage1-vs-Stage3 |
4.191800E-02 |
| Stage1-vs-Stage4 |
1.556010E-01 |
| Stage2-vs-Stage3 |
1.542210E-01 |
| Stage2-vs-Stage4 |
3.348200E-01 |
| Stage3-vs-Stage4 |
8.377200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.206600E-01 |
| Normal-vs-AfricanAmerican |
3.651000E-01 |
| Normal-vs-Asian |
3.767000E-01 |
| Caucasian-vs-AfricanAmerican |
4.021800E-01 |
| Caucasian-vs-Asian |
3.914000E-01 |
| AfricanAmerican-vs-Asian |
8.040000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.150800E-01 |
| Normal-vs-Female |
4.457700E-02 |
| Male-vs-Female |
4.544000E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
5.993200E-01 |
| Normal-vs-Extreme_Weight |
5.820400E-01 |
| Normal-vs-Obese |
3.169600E-01 |
| Normal-vs-Extreme_Obese |
4.939600E-01 |
| Normal_Weight-vs-Extreme_Weight |
1.808160E-01 |
| Normal_Weight-vs-Obese |
5.981800E-01 |
| Normal_Weight-vs-Extreme_Obese |
2.782800E-01 |
| Extreme_Weight-vs-Obese |
3.704000E-02 |
| Extreme_Weight-vs-Extreme_Obese |
6.800800E-01 |
| Obese-vs-Extreme_Obese |
1.726780E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.212120E-02 |
| Normal-vs-Age(41-60Yrs) |
8.588000E-02 |
| Normal-vs-Age(61-80Yrs) |
5.583800E-01 |
| Normal-vs-Age(81-100Yrs) |
3.446500E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.189400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.413630E-04 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.353400E-04 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.000530E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.80210000000037E-05 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.389800E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
5.630000E-01 |
| Normal-VS-Type2 PRCC |
8.335800E-01 |
| Normal-VS-KIRP CIMP |
2.710100E-02 |
| Normal-VS-Unclassified PRCC |
4.288400E-01 |
| Type1 PRCC-VS-Type2 PRCC |
2.829200E-01 |
| Type1 PRCC-VS-KIRP CIMP |
6.368400E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
7.589200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.580000E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
2.915400E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
7.637600E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.467800E-01 |
| Normal-vs-N1 |
4.742300E-02 |
| Normal-vs-N2 |
1.208220E-01 |
| N0-vs-N1 |
3.075700E-02 |
| N0-vs-N2 |
5.654500E-02 |
| N1-vs-N2 |
9.191400E-01 |
|
|
